118 related articles for article (PubMed ID: 17266640)
21. Sobetirome: a case history of bench-to-clinic drug discovery and development.
Scanlan TS
Heart Fail Rev; 2010 Mar; 15(2):177-82. PubMed ID: 19002578
[TBL] [Abstract][Full Text] [Related]
22. Development of a thyroid hormone receptor targeting conjugate.
Zheng J; Hashimoto A; Putnam M; Miller K; Koh JT
Bioconjug Chem; 2008 Jun; 19(6):1227-34. PubMed ID: 18507428
[TBL] [Abstract][Full Text] [Related]
23. Thyroid receptor β: A promising target for developing novel anti-androgenetic alopecia drugs.
Zhi J; Li F; Jiang X; Bai R
Drug Discov Today; 2024 Jun; 29(6):104013. PubMed ID: 38705510
[TBL] [Abstract][Full Text] [Related]
24. Cardiac specific effects of thyroid hormone analogues.
Danzi S; Klein I
Horm Metab Res; 2011 Oct; 43(11):737-42. PubMed ID: 22009366
[TBL] [Abstract][Full Text] [Related]
25. In vivo evaluation of 1-benzyl-4-aminoindole-based thyroid hormone receptor β agonists: importance of liver selectivity in drug discovery.
Takahashi N; Asano Y; Maeda K; Watanabe N
Biol Pharm Bull; 2014; 37(7):1103-8. PubMed ID: 24989002
[TBL] [Abstract][Full Text] [Related]
26. Expression of thyroid hormone receptors A and B in developing rat tissues; evidence for extensive posttranscriptional regulation.
Keijzer R; Blommaart PJ; Labruyère WT; Vermeulen JL; Doulabi BZ; Bakker O; Tibboel D; Lamers WH
J Mol Endocrinol; 2007 May; 38(5):523-35. PubMed ID: 17496154
[TBL] [Abstract][Full Text] [Related]
27. 2D QSAR studies on thyroid hormone receptor ligands.
Valadares NF; Castilho MS; Polikarpov I; Garratt RC
Bioorg Med Chem; 2007 Jul; 15(13):4609-17. PubMed ID: 17467994
[TBL] [Abstract][Full Text] [Related]
28. Thyroid hormone analogues for the treatment of metabolic disorders: new potential for unmet clinical needs?
Shoemaker TJ; Kono T; Mariash CN; Evans-Molina C
Endocr Pract; 2012; 18(6):954-64. PubMed ID: 22784847
[TBL] [Abstract][Full Text] [Related]
29. Targeting thyroid hormone receptor-beta agonists to the liver reduces cholesterol and triglycerides and improves the therapeutic index.
Erion MD; Cable EE; Ito BR; Jiang H; Fujitaki JM; Finn PD; Zhang BH; Hou J; Boyer SH; van Poelje PD; Linemeyer DL
Proc Natl Acad Sci U S A; 2007 Sep; 104(39):15490-5. PubMed ID: 17878314
[TBL] [Abstract][Full Text] [Related]
30. Thyroid receptor ligands. Part 7: Indirect antagonists of the thyroid hormone receptor with improved affinity.
Malm J; Gordon S; Brandt P; Carlsson B; Agback P; Bäckbro Saeidi A; Sandberg J
Bioorg Med Chem Lett; 2007 Apr; 17(7):2018-21. PubMed ID: 17254783
[TBL] [Abstract][Full Text] [Related]
31. Thyroid hormone receptor-specific interactions with steroid receptor coactivator-1 in the pituitary.
Sadow PM; Koo E; Chassande O; Gauthier K; Samarut J; Xu J; O'Malley BW; Seo H; Murata Y; Weiss RE
Mol Endocrinol; 2003 May; 17(5):882-94. PubMed ID: 12576486
[TBL] [Abstract][Full Text] [Related]
32. Thyroid receptor ligands. 3. Design and synthesis of 3,5-dihalo-4-alkoxyphenylalkanoic acids as indirect antagonists of the thyroid hormone receptor.
Hedfors A; Appelqvist T; Carlsson B; Bladh LG; Litten C; Agback P; Grynfarb M; Koehler KF; Malm J
J Med Chem; 2005 May; 48(9):3114-7. PubMed ID: 15857115
[TBL] [Abstract][Full Text] [Related]
33. Synthesis and pharmacological characterization of 1-benzyl-4-aminoindole-based thyroid hormone receptor β agonists.
Takahashi N; Maeda K; Asano Y; Watanabe N
Bioorg Med Chem; 2014 Jan; 22(1):488-98. PubMed ID: 24290064
[TBL] [Abstract][Full Text] [Related]
34. On the denaturation mechanisms of the ligand binding domain of thyroid hormone receptors.
Martínez L; Souza PC; Garcia W; Batista FA; Portugal RV; Nascimento AS; Nakahira M; Lima LM; Polikarpov I; Skaf MS
J Phys Chem B; 2010 Jan; 114(3):1529-40. PubMed ID: 20043653
[TBL] [Abstract][Full Text] [Related]
35. Molecular modeling revealed that ligand dissociation from thyroid hormone receptors is affected by receptor heterodimerization.
Zhuang S; Bao L; Linhananta A; Liu W
J Mol Graph Model; 2013 Jul; 44():155-60. PubMed ID: 23831995
[TBL] [Abstract][Full Text] [Related]
36. Selective thyroid hormone receptor β agonists with oxadiazolone acid isosteres.
Kirschberg TA; Jones CT; Xu Y; Fenaux M; Halcomb RL; Wang Y; Klucher K
Bioorg Med Chem Lett; 2020 Nov; 30(21):127465. PubMed ID: 32768645
[TBL] [Abstract][Full Text] [Related]
37. Lack of mutations in the thyroid hormone receptor (TR) alpha and beta genes but frequent hypermethylation of the TRbeta gene in differentiated thyroid tumors.
Joseph B; Ji M; Liu D; Hou P; Xing M
J Clin Endocrinol Metab; 2007 Dec; 92(12):4766-70. PubMed ID: 17911173
[TBL] [Abstract][Full Text] [Related]
38. Thyroid hormone receptor subtype specificity for hormone-dependent neurogenesis in Xenopus laevis.
Denver RJ; Hu F; Scanlan TS; Furlow JD
Dev Biol; 2009 Feb; 326(1):155-68. PubMed ID: 19056375
[TBL] [Abstract][Full Text] [Related]
39. Effects of thyroid hormone analogs on lipid metabolism and thermogenesis.
Ribeiro MO
Thyroid; 2008 Feb; 18(2):197-203. PubMed ID: 18279020
[TBL] [Abstract][Full Text] [Related]
40. Molecular cloning and mRNA tissue expression of thyroid hormone receptors in yellow catfish Pelteobagrus fulvidraco and Javelin goby Synechogobius hasta.
Chen QL; Luo Z; Tan XY; Pan YX; Zheng JL; Zou M
Gene; 2014 Feb; 536(2):232-7. PubMed ID: 24380707
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
